Page 87 - Sohini Das

Second Covid-19 wave: Primary health centres see a rush for vaccine

On ground, manpower concern as drive expands to rural, semi-urban areas

India delays big exports of AstraZeneca vaccine as Covid-19 cases surge

India is, however, not officially banning Covid-19 vaccine exports. "This is a temporary move until the supply situation stabilises in the country," said a person close to the development

Covaxin manufacturing may get a booster shot as demand for vaccines grows

Bharat Biotech also has another site at Bengaluru that is currently making vaccines other than Covaxin

Supply slipping, Centre to speed up Covid-19 vaccine delivery to states

Vaccine makers asked to send more doses to central government on priority

States on overdrive to reduce vaccine wastage as Covid-19 cases rise

Experts say controlling spoilage with 10-dose vials may give vax drive a shot in the arm

Will supply more doses of AstraZeneca vaccine to UK later, says Serum

Senior officials in New Delhi confirmed that there was no ban on exports from India, and no plans to do so either.

Mumbai hospitals stare at bed crunch amid spike in Covid-19 cases

As Covid cases rise, pvt hospitals say situation could get critical in 2 weeks if momentum continues

Supply challenges for auto-disable syringe needle private hospitals

So far, the syringes were being supplied by the state government

Covaxin shows 81% efficacy in phase-3 trials, says Bharat Biotech

Firm is gearing up to produce 40 million doses a month. Two Bio-safety Level-3 facilities (which can deal with deadly and contagious viruses) have been set up, third is on the way

European Union drug regulator audits manufacturing site of Serum Institute

AstraZeneca Chief Executive (CEO) Pascal Soriot has indicated that the company may look at factories outside of the EU to meet the supply commitments.

Vaccination 2.0 gets off to a slow start in Mumbai due to tech issues

Turnout is encouraging for this round, glitch resolved after one-hour delay, say facilities

RT-PCR kit makers tweaking kits to detect new coronavirus strains

The country's apex health research body, Indian Council of Medical Research (ICMR), is receiving proposals from kit makers in this regard

CoWin registration from 9am today as India enters next phase of vaccination

The private sector is poised for a bigger and more active role in administering the life-saving jab.

Idle capacities at labs as 'gold standard' tests for detecting Covid fall

Fewer RT-PCR tests than capacity at many places; non-Covid tests pick up

Bharat Biotech signs deal to send 20 mn Covaxin doses to Brazil

Shipments to be made during second and third quarters of current calendar

Hospitals turn to pre-Covid biz as patients prefer home quarantine

The number of Covid beds dropped to 1,600 during the third quarter, and further dropped to 800 in January

PLI scheme: Pharma industry expects more guidelines on investment

B R Sikri, chairman of the Federation of Pharma Entrepreneurs, said, higher incentives would have meant more production of cancer drugs, thereby, bringing down their prices

Centre announces Rs 15,000 crore PLI for pharma, IT hardware sectors

Pharma scheme aims at Rs 3 trillion incremental sales, 100,000 jobs; experts say hardware scheme to help India become electronics manufacturing hub for the world

Ukraine keen on Bharat Biotech's Covaxin, sends team to negotiate supply

Three-member delegation led by nation's health minister visits Hyderabad unit, discusses timeline for delivery of shots on priority, and prospects of a tie-up for teh firm;s intranasal vaccine

Expert panel asks DRL to come back with more data on Sputnik safety

DRL applied for restricted emergency use of Sputnik V last week, has lined up 250 mn doses for Indians over next 12 months